Neuralink Second Patient: ALS Patient Drinks Coffee via Brain-Controlled Robotic Arm
Neuralink reveals second N2 implant patient's progress: ALS patient Mark successfully drank coffee using mind-controlled robotic arm, a major breakthrough for BCI clinical applications.
Neuralink today revealed progress of the second human subject with N2 chip. ALS patient Mark successfully drank coffee by mentally controlling a robotic arm.
Technical Achievement
Despite complete loss of motor function from ALS, Mark can:
- Mentally control computer cursor
- Operate robotic arm for fine movements
- Type at 30 characters/minute
- Maintain 98% long-term accuracy
Clinical Significance
This offers major hope for ALS patients, spinal cord injury patients, and others with motor neuron diseases. Neuralink has submitted FDA Breakthrough Device Designation application.
Next Steps
Neuralink plans to recruit a third subject and begin clinical trials for quadriplegic patients.
Disclaimer
Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.